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EDITORIAL
The 2015 Ming K Jeang Award 
for Excellence in Cell & Bioscience
Yun‑Bo Shi*
Abstract 
Two research groups led by Dr. Bin Gao of National Institute on Alcohol Abuse and Alcoholism, National Institutes of 
Health, MD, USA and Dr. Keji Zhao of National Heart, Lung, and Blood Institute, National Institutes of Health, MD, USA, 
respectively, won the 2015 Ming K Jeang Award for excellence in Cell & Bioscience.
© 2016 Shi. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://
creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided 
you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate 
if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/
zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Editorial
We are very pleased to announce that two research 
groups, who each published an outstanding research 
article in Cell & Bioscience in 2015, have been selected 
to receive the Ming K Jeang Award for excellence in Cell 
& Bioscience. The Ming K Jeang Award for excellence in 
Cell & Bioscience was established in 2011 with a gener-
ous donation from the Ming K. Jeang Foundation to 
honor outstanding research articles published in Cell & 
Bioscience, the official journal of the Society of Chinese 
Bioscientists in America (SCBA; www.scbasociety.org). 
A committee of Cell & Bioscience editors, chaired by Dr. 
Dong-Yan Jin, considered all research articles published 
in the journal in 2015 to select the following two articles 
to receive the award [1, 2]:
Biologically active, high levels of interleukin-22 inhibit 
hepatic gluconeogenesis but do not affect obesity and its 
metabolic consequences
Ogyi Park, Sung Hwan Ki, Mingjiang Xu, Hua Wang, 
Dechun Feng, Joseph Tam, Douglas Osei-Hyiaman, 
George Kunos and Bin Gao Cell & Bioscience 2015 
5:25
Division of labor between IRF1 and IRF2 in regulating 
different stages of transcriptional activation in cellular 
antiviral activities
Gang Ren, Kairong Cui, Zhiying Zhang and Keji Zhao 
Cell & Bioscience 2015 5:17
Congratulations to these two groups of investigators 
for jobs well done!
We are looking forward to receiving contributions of 
outstanding research articles from the scientific commu-
nity in 2016 and beyond.
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